Brochure
14 May 2026

Lyophilization Cycle Development of Pharmaceutical Products

PDF 972 kB

Fresenius Kabi CMO can produce and characterize batches to identify optimal and scalable freeze dry cycle parameters for your drug products.

Content provided by our supplier

Fresenius Kabi Contract Manufacturing

  • Country/Region:
    United States
  • On CPHI since:
    2024
  • Certificates:
    5
  • Employees:
    5000+
Company types
CMO/CDMO
Contract Service
Manufacturer/Innovator
Pharmaceutical company
Primary activities
API Producer
Biopharmaceutical
Contract Manufacturer
Pharmaceutical Company (generic finished products)

Other Content from Fresenius Kabi Contract Manufacturing (10)

  • Brochure Brochure - Fresenius Kabi Contract Manufacturing

    At Fresenius Kabi, we know how important choosing a reliable contract manufacturer is to your organization. You can count on us for quality and compliance.
  • Brochure Fresenius Kabi CMO website

    For more information, contact the Contract Manufacturing team, visit cmo.fresenius-kabi.com, or email us at [email protected]
  • Brochure Fresenius Kabi brings you More in America for your CDMO Contract needs

    Discussion on Fresenius Kabi's Contract Manufacturing capabilities in the US
  • Industry Webinar Be Prepared! Combination Products under MDR - Article 117

    This extremely topical webinar addresses the challenge that the complex European Medical Device Regulation (MDR) poses for the entire industry, with a special focus on drug combination products and the requirements of Article 117.

    Join Heinrich Martens, Vice Regulatory Affairs, Fresenius Kabi and Jonas Orf, Junior Key Account Manager, Fresenius Kabi as they shed light on the new requirements of MDR including stricter pre-market control, oversight of notified bodies, inclusion of products without medical purpose and rules on clinical data and clinical investigations.

    They also provide an introduction to the drug combination ‘world’ within the context of MDR Article 117, the role of the Notified Body, fulfilment of the General Safety and Performance Requirements (GSPRs) and responsibilities and obligations of the manufacturer(s).

    “In the MDD world that we had in the past, we had the essential requirements, which were similar to the GSPRs, but there was never anything about a Notified Body opinion, an additional approval step for the device that was required for a drug combination submission to the authority,” says Martens. “Which is totally different when you look now into Article 117.”

    By watching this webinar, you will understand:
    What is a combination product

    The meaning of Article 117

    The role and task of the Notified Body

    Manufacturer responsibilities

    Evidence and fulfilment of the GSPRs

    Notified Body opinion

  • Video Your Partner for Diluents

    As a specialist in diluent solutions Fresenius Kabi is the right partner for you. We offer solutions, that fit together with your needs. Find out more about our diluent production in this video
  • Brochure Fresenius Kabi Contract Manufacturing Brochure

    Find out about our Contract Manufacturing and fill- and finishing services for sterile pharmaceuticals and medical devices. We offer different containers in various sizes like pre-filled syringes, ampoules, vials, bottles and IV-bags.
  • Brochure INSIGHT US

    In our latest INSIGHT edition we introduce our three US facilities and our new US team.
  • Brochure INSIGHT IV-bags and medical devices

    This INSIGHT edition sheds light on our production site in Halden, Norway, our IV-bag capabilities and our medical devices expertise.